Introduction: Current prognostic models for chronic kidney disease (CKD) are complex and were designed to predict a single outcome. We aimed to develop and validate a simple and parsimonious prognostic model to predict cardio-kidney events and mortality. Methods: Patients from the CRIC Study (n = 3,718) were randomly divided into derivation (n = 2,478) and validation (n = 1,240) cohorts. Twenty-nine candidate variables were preselected. Multivariable Cox regression models were developed using stepwise selection for various cardio-kidney endpoints, namely, (i) the primary composite outcome of 50% decline in estimated glomerular filtration rate (eGFR) from baseline, end-stage renal disease, or cardiovascular (CV) mortality; (ii) hospitalization for heart failure (HHF) or CV mortality; (iii) 3-point major CV endpoints (3P-MACE); (iv) all-cause death. Results: During a median follow-up of 9 years, the primary outcome occurred in 977 patients of the derivation cohort and 501 patients of the validation cohort. Log-transformed N-terminal pro-B-type natriuretic peptide (NT-proBNP), log-transformed high-sensitive cardiac troponin T (hs-cTnT), log-transformed albuminuria, and eGFR were the dominant predictors. The primary outcome risk score discriminated well (c-statistic = 0.83) with a proportion of events of 11.4% in the lowest tertile of risk and 91.5% in the highest tertile at 10 years. The risk model presented good discrimination for HHF or CV mortality, 3P-MACE, and all-cause death (c-statistics = 0.80, 0.75, and 0.75, respectively). The 4-variable risk model achieved similar c-statistics for all tested outcomes in the validation cohort. The discrimination of the 4-variable risk model was mostly superior to that of published models. Conclusion: The combination of NT-proBNP, hs-cTnT, albuminuria, and eGFR in a single 4-variable model provides a unique individual prognostic assessment of multiple cardio-kidney outcomes in CKD.

1.
Mendonca
L
,
Bigotte Vieira
M
,
Neves
JS
.
Association of combined fractional excretion of phosphate and FGF23 with heart failure and cardiovascular events in moderate and advanced renal disease
.
J Nephrol
.
2023
;
36
(
1
):
55
67
.
2.
Grams
ME
,
Yang
W
,
Rebholz
CM
,
Wang
X
,
Porter
AC
,
Inker
LA
.
Risks of adverse events in advanced CKD: the chronic renal insufficiency cohort (CRIC) study
.
Am J Kidney Dis
.
2017
;
70
(
3
):
337
46
.
3.
Smekal
MD
,
Tam-Tham
H
,
Finlay
J
,
Donald
M
,
Benterud
E
,
Thomas
C
.
Perceived benefits and challenges of a risk-based approach to multidisciplinary chronic kidney disease care: a qualitative descriptive study
.
Can J Kidney Health Dis
.
2018
;
5
:
2054358118763809
.
4.
Bundy
JD
,
Rahman
M
,
Matsushita
K
,
Jaeger
BC
,
Cohen
JB
,
Chen
J
.
Risk prediction models for atherosclerotic cardiovascular disease in patients with chronic kidney disease: the CRIC study
.
J Am Soc Nephrol
.
2022
;
33
(
3
):
601
11
.
5.
Zelnick
LR
,
Shlipak
MG
,
Soliman
EZ
,
Anderson
A
,
Christenson
R
,
Kansal
M
.
Prediction of incident heart failure in CKD: the CRIC study
.
Kidney Int Rep
.
2022
;
7
(
4
):
708
19
.
6.
Janus
SE
Multi-variable biomarker approach in identifying incident heart failure in chronic kidney disease results from the chronic renal insufficiency cohort (CRIC) study
European Journal of Heart Failure
2022
.
7.
Ali
I
,
Kalra
P
.
Risk prediction in chronic kidney disease
.
Curr Opin Nephrol Hypertens
.
2019
;
28
(
6
):
513
8
.
8.
Tangri
N
,
Stevens
LA
,
Griffith
J
,
Tighiouart
H
,
Djurdjev
O
,
Naimark
D
.
A predictive model for progression of chronic kidney disease to kidney failure
.
JAMA
.
2011
;
305
(
15
):
1553
9
.
9.
Grams
ME
,
Sang
Y
,
Ballew
SH
,
Carrero
JJ
,
Djurdjev
O
,
Heerspink
HJL
.
Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate
.
Kidney Int
.
2018
;
93
(
6
):
1442
51
.
10.
Feldman
HI
,
Appel
LJ
,
Chertow
GM
,
Cifelli
D
,
Cizman
B
,
Daugirdas
J
.
The chronic renal insufficiency cohort (CRIC) study: design and methods
.
J Am Soc Nephrol
.
2003
14
7 Suppl 2
S148
53
.
11.
Lash
JP
,
Go
AS
,
Appel
LJ
,
He
J
,
Ojo
A
,
Rahman
M
.
Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function
.
Clin J Am Soc Nephrol
.
2009
;
4
(
8
):
1302
11
.
12.
Bansal
N
,
Hyre Anderson
A
,
Yang
W
,
Christenson
RH
,
deFilippi
CR
,
Deo
R
.
High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study
.
J Am Soc Nephrol
.
2015
;
26
(
4
):
946
56
.
13.
Amdur
RL
,
Feldman
HI
,
Gupta
J
,
Yang
W
,
Kanetsky
P
,
Shlipak
M
.
Inflammation and progression of CKD: the CRIC study
.
Clin J Am Soc Nephrol
.
2016
;
11
(
9
):
1546
56
.
14.
Gupta
J
,
Mitra
N
,
Kanetsky
PA
,
Devaney
J
,
Wing
MR
,
Reilly
M
.
Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC
.
Clin J Am Soc Nephrol
.
2012
;
7
(
12
):
1938
46
.
15.
Uno
H
,
Cai
T
,
Pencina
MJ
,
D’Agostino
RB
,
Wei
LJ
.
On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data
.
Stat Med
.
2011
;
30
(
10
):
1105
17
.
16.
Agarwal
SK
,
Chambless
LE
,
Ballantyne
CM
,
Astor
B
,
Bertoni
AG
,
Chang
PP
.
Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study
.
Circ Heart Fail
.
2012
;
5
(
4
):
422
9
.
17.
Orlandi
PF
,
Fujii
N
,
Roy
J
,
Chen
HY
,
Lee Hamm
L
,
Sondheimer
JH
.
Hematuria as a risk factor for progression of chronic kidney disease and death: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study
.
BMC Nephrol
.
2018
;
19
(
1
):
150
11
.
18.
Santos-Araújo
C
,
Leite-Moreira
A
,
Pestana
M
.
Clinical value of natriuretic peptides in chronic kidney disease
.
Nefrologia
.
2015
;
35
(
3
):
227
33
.
19.
Untersteller
K
,
Girerd
N
,
Duarte
K
,
Rogacev
KS
,
Seiler-Mussler
S
,
Fliser
D
.
NT-proBNP and echocardiographic parameters for prediction of cardiovascular outcomes in patients with CKD stages G2–G4
.
Clin J Am Soc Nephrol
.
2016
;
11
(
11
):
1978
88
.
20.
Linssen
GC
,
Bakker
SJL
,
Voors
AA
,
Gansevoort
RT
,
Hillege
HL
,
de Jong
PE
.
N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population
.
Eur Heart J
.
2010
;
31
(
1
):
120
7
.
21.
Matsushita
K
,
Sang
Y
,
Ballew
SH
,
Astor
BC
,
Hoogeveen
RC
,
Solomon
SD
.
Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study
.
Arterioscler Thromb Vasc Biol
.
2014
;
34
(
8
):
1770
7
.
22.
Desai
AS
,
Toto
R
,
Jarolim
P
,
Uno
H
,
Eckardt
KU
,
Kewalramani
R
.
Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD
.
Am J Kidney Dis
.
2011
;
58
(
5
):
717
28
.
23.
Roffi
M
,
Patrono
C
,
Collet
JP
,
Mueller
C
,
Valgimigli
M
,
Andreotti
F
.
2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
.
Kardiol Pol
.
2015
;
73
(
12
):
1207
94
.
24.
Michos
ED
,
Wilson
LM
,
Yeh
HC
,
Berger
Z
,
Suarez-Cuervo
C
,
Stacy
SR
.
Prognostic value of cardiac troponin in patients with chronic kidney disease without suspected acute coronary syndrome: a systematic review and meta-analysis
.
Ann Intern Med
.
2014
;
161
(
7
):
491
501
.
25.
Scheven
L
,
de Jong
PE
,
Hillege
HL
,
Lambers Heerspink
HJ
,
van Pelt
LJ
,
Kootstra
JE
.
High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate
.
Eur Heart J
.
2012
;
33
(
18
):
2272
81
.
26.
Rørth
R
,
Jhund
PS
,
Kristensen
SL
,
Desai
AS
,
Køber
L
,
Rouleau
JL
.
The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes
.
Eur J Heart Fail
.
2019
;
21
(
1
):
40
9
.
27.
Pocock
SJ
,
Ferreira
JP
,
Gregson
J
,
Anker
SD
,
Butler
J
,
Filippatos
G
.
Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial
.
Eur Heart J
.
2021
;
42
(
43
):
4455
64
.
28.
Levin
A
.
Kidney Disease: improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease
.
Kidney Int Suppl
.
2013
;
3
(
1
):
1
150
.
29.
Chronic Kidney Disease Prognosis Consortium
Matsushita
K
,
van der Velde
M
,
Astor
BC
,
Woodward
M
,
Levey
AS
.
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
.
Lancet
.
2010
;
375
(
9731
):
2073
81
.
30.
Bouma-de Krijger
A
,
Vervloet
MG
.
Fibroblast growth factor 23: are we ready to use it in clinical practice
.
J Nephrol
.
2020
;
33
(
3
):
509
27
.
You do not currently have access to this content.